105 related articles for article (PubMed ID: 11791359)
1. [Economic aspects of osteoporosis therapy. What does a prevented fracture cost?].
Kruse HP
MMW Fortschr Med; 2001 Nov; 143(47):33-6. PubMed ID: 11791359
[No Abstract] [Full Text] [Related]
2. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of alternative treatments for women with osteoporosis in Canada.
Goeree R; Blackhouse G; Adachi J
Curr Med Res Opin; 2006 Jul; 22(7):1425-36. PubMed ID: 16834841
[TBL] [Abstract][Full Text] [Related]
4. [Update 2004. Osteoporosis--management--current status].
Bartl R
Krankenpfl J; 2004; 42(7-10):232. PubMed ID: 15675394
[No Abstract] [Full Text] [Related]
5. [Risk of osteoporosis in postmenopausal women. When is bone density measurement indicated?].
MMW Fortschr Med; 2004 May; 146(21):63. PubMed ID: 15373093
[No Abstract] [Full Text] [Related]
6. [Cost-effectiveness of alendronate treatment of osteoporosis in Denmark. An economic evaluation based on the Fracture Intervention Trial].
Jönsson L; Borgström F; Zethraeus N
Ugeskr Laeger; 2003 Oct; 165(43):4112-6. PubMed ID: 14619061
[No Abstract] [Full Text] [Related]
7. [Osteoporosis. Fracture as alarm signal].
MMW Fortschr Med; 2001 Oct; 143(41):56. PubMed ID: 11721665
[No Abstract] [Full Text] [Related]
8. Universal bone densitometry screening combined with alendronate therapy for those diagnosed with osteoporosis is highly cost-effective for elderly women.
Schousboe JT; Ensrud KE; Nyman JA; Melton LJ; Kane RL
J Am Geriatr Soc; 2005 Oct; 53(10):1697-704. PubMed ID: 16181168
[TBL] [Abstract][Full Text] [Related]
9. A cost effectiveness analysis of calcium and vitamin D supplementation, etidronate, and alendronate in the prevention of vertebral fractures in women treated with glucocorticoids.
Buckley LM; Hillner BE
J Rheumatol; 2003 Jan; 30(1):132-8. PubMed ID: 12508402
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of the effects of treatment of osteoporosis].
Christensen PM; Sørensen HA; Vestergaard P
Ugeskr Laeger; 2005 Feb; 167(9):1031-3. PubMed ID: 15803999
[No Abstract] [Full Text] [Related]
11. [Routine osteoporosis therapy].
Ringe JD
Krankenpfl J; 2004; 42(7-10):233. PubMed ID: 15675395
[No Abstract] [Full Text] [Related]
12. Cost-effectiveness of alendronate in the treatment of postmenopausal women in 9 European countries--an economic evaluation based on the fracture intervention trial.
Ström O; Borgström F; Sen SS; Boonen S; Haentjens P; Johnell O; Kanis JA
Osteoporos Int; 2007 Aug; 18(8):1047-61. PubMed ID: 17333449
[TBL] [Abstract][Full Text] [Related]
13. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
Ettinger MP
Arch Intern Med; 2003 Oct; 163(18):2237-46. PubMed ID: 14557222
[TBL] [Abstract][Full Text] [Related]
14. Pharmacoeconomic analysis of osteoporosis treatment with risedronate.
Brecht JG; Kruse HP; Felsenberg D; Möhrke W; Oestreich A; Huppertz E
Int J Clin Pharmacol Res; 2003; 23(4):93-105. PubMed ID: 15224498
[TBL] [Abstract][Full Text] [Related]
15. [Osteoporosis compounds in general practice. That is REAL: in routine practice the better choice].
MMW Fortschr Med; 2007 Mar; 149(13):50. PubMed ID: 17672400
[No Abstract] [Full Text] [Related]
16. Canadian consensus on osteoporosis. Preventing osteoporosis among postmenopausal women.
Can Fam Physician; 2003 Apr; 49():487. PubMed ID: 12729244
[No Abstract] [Full Text] [Related]
17. [Therapy of osteoporosis. Risk factors alone are not an indication].
MMW Fortschr Med; 2001 Dec; 143(49-50):57. PubMed ID: 11813710
[No Abstract] [Full Text] [Related]
18. [Bisphosphonates in osteoporosis. Significantly reduces risk of fracture].
MMW Fortschr Med; 2001 May; 143(18):53. PubMed ID: 11393183
[No Abstract] [Full Text] [Related]
19. [Data comparison of osteoporosis patients demonstrates nasal administration is not optimal].
MMW Fortschr Med; 2004 Feb; 146(7):62. PubMed ID: 15347062
[No Abstract] [Full Text] [Related]
20. Pharmacologic prevention of osteoporotic fractures.
Zizic TM
Am Fam Physician; 2004 Oct; 70(7):1293-300. PubMed ID: 15508540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
